Alphabet launches AI-driven drug discovery start-up Isomorphic Labs
Google’s parent company Alphabet has launched an AI-driven drug discovery start-up. the aim of this is to use artificial intelligence for drug discovery. The main objective of the company is to use AI (artificial intelligence) to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases.
- Google’s new company will be known as Isomorphic Laboratories and Demis Hassabis will be the CEO of Isomorphic Labs.
- The London-based Isomorphic Labs will focus on the most important applications of AI — in the field of biological and medical research.
For all the latest Updates, download PrepareExams App.